ASSENT III

Assessment of the Safety and Efficacy of New Thrombolytic Regimens

Stadium: klaar
Middel: tenecteplase
Populatie: ASCVD
Fase: III
First Patient In: -
Last Patient In: -
Last Patient Last Visit: -